No black box warning on record for Octreotide Acetate

As of the latest FDA labeling reviewed, Octreotide Acetate (OCTREOTIDE ACETATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Octreotide Acetate medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Cardiac Function Abnormalities : Increased risk for higher degree of atrioventricular blocks. Consider cardiac monitoring in patients receiving octreotide acetate injection intravenously. Bradycardia, arrhythmias, or conduction abnormalities may occur. Use with caution in at-risk patients. Dosage adjustment of cardiac medications may be necessary. ( 5.1 ) Cholelithiasis

No black box warning on record for Octreotide Acetate

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Cardiac Function Abnormalities : Increased risk for higher degree of atrioventricular blocks. Consider cardiac monitoring in patients receiving octreotide acetate injection intravenously. Bradycardia, arrhythmias, or conduction abnormalities may occur. Use with caution in at-risk patients. Dosage adjustment of cardiac medications may be necessary. ( 5.1 ) Cholelithiasis

Octreotide Acetate Black Box Warning

No black box warning on record for Octreotide Acetate

Other warnings & precautions

Octreotide Acetate Black Box Warning

No black box warning on record for Octreotide Acetate

Other warnings & precautions